MTL - Returning to ’90s, She Became Famous in Major Surgical Fields-Chapter 3824 【3824】not optimistic
Everyone scrambled to discuss, and almost unanimously agreed on this answer.
Obviously, no one except Mr. Ren can afford to be the chief surgeon today.
If Ren Zhelun can't afford it, Zhang Huayao can only carry it by himself.
Someone on the stage was beating the microphone to signal silence, indicating that the live broadcast of the surgery was about to begin.
Director Fang revealed another piece of information. She had been to a patient to visit an old friend who was about to undergo an operation before, and she was in vain, indicating that the patient had already been sent to the operating room.
It seems that this gamble operation by Big Boss Zhang and his people is imperative.
Everyone has solemn expressions.
Later see Dr. Lu walking up to the front podium.
Dr. Lu Zhibin in a black suit and gold tie, in such a cool outfit, looks like a little devil under the big devil Zhang. Picking up the microphone, Dr. Lu announced loudly: "Everyone is welcome to accept our invitation and come to Guozhi to watch our surgery."
It seems that a heartbeat can be smelled at the scene.
Teacher Lu couldn't help scratching the clothes on his chest: I'm so nervous.
Director Fang quickly patted her on the back.
"Is it a full robotic surgery?"
Someone in the audience couldn't wait to ask questions first.
"Yes." Lu Zhibin answered readily.
The guests in the audience seemed to be able to see his brilliant confidence, and they were even more puzzled: As the world's first challenge, the people of this big brother and Zhang big brother are not afraid? Is it true that some mysterious magic weapon is guaranteed?
"Let me show you the case introduction first." Lu Zhibin shouted.
The assistant below immediately turned on the computer ppt and projected it on the big screen behind him.
There are a large number of cardiac surgeons sitting under the stage, and they can grasp the key points from the medical records on the curtain with a few glances.
Someone raised a voice of surprise: "Are you planning to perform surgery on the patient with four-vessel disease?"
"yes."
The world's first case, it must be more difficult to challenge, at least it is more difficult than the successful operation of company B.
A large group of people stared at the people of Company B.
The facial expressions of the gringos in the front row are much calmer.
If you listen carefully to the discussions of these gringos after they came here, you will find that they are all about targeted weaknesses.
One is that the four-vessel disease is indeed a surgery case that Company B cannot complete for the time being. The technical difficulties here are only well understood by the people of Company B, who know that they cannot be overcome with existing technology, and this is not a difficulty that Company B can overcome by itself.
As mentioned before, the full flowering of new surgical technologies requires the assistance of multiple other technologies. To what extent surgical robots can achieve requires the cooperation of technological advancements in other fields. Such a task cannot be solved by Company B or other surgical robot companies alone.
In addition to Company B, the editors of other medical journals here have a clearer and better understanding of the latest technical information in the field of medicine than Company B, because their task is to review this information every day.
It can be said with certainty that these foreigners may understand far better than the domestic people the difficulties and obstacles Mr. Zhang and the others are facing today.
Bi Yongqing and the others can see that Hans, the vice president of Company B, is shaking his head. This shake of the head expresses disbelief about today's surgery.
On the other hand, Representative Gong said: "If it was Doctor Ren who performed the surgery—"
Different from Bi Yongqing and others, people in commercial companies know that if Ren Zhelun performed today's operation, it would be meaningless.
The selling point of the surgical robot is to target general clinical doctors rather than Ren Zhelun, a master who researches robots himself. Their company B never uses their own laboratory bosses for publicity, and people outside will suspect that they are fraudulent.
